Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
The LancetPublished 1 February 1999
Lennart Hansson, Lars Lindholm, Leo Niskanen, Jan Lanke, Thomas Hedner, Anders Niklason
Citations2,009
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Captopril and conventional treatment did not differ in efficacy in preventing cardiovascular morbidity and mortality and the difference in stroke risk was probably due to the lower levels of blood pressure obtained initially in previously treated patients randomised to conventional therapy.
Abstract
Captopril and conventional treatment did not differ in efficacy in preventing cardiovascular morbidity and mortality. The difference in stroke risk is probably due to the lower levels of blood pressure obtained initially in previously treated patients randomised to conventional therapy.
Keywords
Medicine
New England Journal of MedicineEffect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
5,925 Citations1992Marc A. Pfeffer, Eugene Braunwald +16 more
In patients with asymptomatic left ventricular dysfunction after myocardial infarction, long-term administration of captopril was associated with an improvement in survival and reduced morbidity and mortality due to major cardiovascular events.
The LancetEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
5,765 Citations1998Lennart Hansson, Alberto Zanchetti +8 more
Intensive lowering of blood pressure in patients with hypertension was associated with a low rate of cardiovascular events and the potential benefit of a low dose of acetylsalicylic acid in the treatment of hypertension was assessed.
New England Journal of MedicinePrognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study
5,709 Citations1990Daniel Levy, Robert J. Garrison +3 more
The estimation of left ventricular mass by echocardiography offers prognostic information beyond that provided by the evaluation of traditional cardiovascular risk factors, and it is concluded that an increase in left Ventricular mass predicts a higher incidence of clinical events, including death, attributable to cardiovascular disease.
Archives of Internal MedicineThe sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure
5,669 Citations1997
New England Journal of MedicineThe Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
5,377 Citations1993Edmund J. Lewis, Lawrence G. Hunsicker +2 more
Captopril protects against deterioration in renal function in insulin-dependent diabetic nephropathy and is significantly more effective than blood-pressure control alone.
The LancetBlood pressure, stroke, and coronary heart disease
4,511 Citations1990Rory Collins, Richard Peto +12 more
A sufficiently high risk of stroke (perhaps because of age, blood pressure, or, in particular, history of cerebrovascular disease) may be the clearest indication for antihypertensive treatment.
Archives of Internal MedicineThe Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
3,779 Citations1997
In older persons, diuretics are preferred and long-acting dihydropyridine calcium antagonists may be considered and specific therapy for patients with LVH, coronary artery disease, and heart failure are outlined.
The LancetMorbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
1,888 Citations1991Björn Dahlöf, L. Hansson +4 more
It is concluded that antihypertensive treatment in hypertensive men and women aged 70-84 confers highly significant and clinically relevant reductions in cardiovascular morbidity and mortality as well as in total mortality.
Archives of Internal MedicineThe Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
1,604 Citations1993
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
1,408 Citations1998M R Stearne, S L Palmer +261 more
BMJEfficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
1,390 Citations1998UK Prospective Diabetes Study Group,
This study provided no evidence that either drug has any specific beneficial or deleterious effect, suggesting that blood pressure reduction in itself may be more important than the treatment used.
New England Journal of MedicineThe Effects of Antihypertensive Therapy on the Quality of Life
1,343 Citations1986Sydney H. Croog, Sol Levine +6 more
It is shown that antihypertensive agents have different effects on the quality of life and that these can be meaningfully assessed with available psychosocial measures.
BMJMedical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party.
1,337 Citations1992
Hydrochlorothiazide and amiloride reduce the risk of stroke, coronary events, and all cardiovascular events in older hypertensive adults.
New England Journal of MedicineThe Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension
1,175 Citations1998Raymond O. Estacio, Barrett W. Jeffers +4 more
In this population of patients with diabetes and hypertension, a significantly higher incidence of fatal and nonfatal myocardial infarction is found among those assigned to therapy with the calcium-channel blocker nisoldipine than among those assign to receive enalapril.
Archives of Internal MedicineThe 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure
1,097 Citations1988Aram V. Chobanian
This report updates findings of previous reports in several respects: it broadens the step-care approach to provide more flexibility for clinicians; encourages greater patient involvement in the treatment program; emphasizes a consideration of the quality of life in the management of patients; and addresses the cost of care.
American Journal of HypertensionReversal of Left Ventricular Hypertrophy in Hypertensive Patients
929 Citations1992Björn Dahlöf, Kjell Pennert +1 more
Metaanalysis of all available studies that have evaluated the effect of antihypertensive pharmacologic therapy on left ventricular structure examined by echocardiography shows that ACE inhibitors, beta-blockers, and calcium antagonists all reduce LVM by reversing wall hypertrophy, and that the effect is most pronounced with ACE inhibitors.
New England Journal of MedicineA Comparison of the Effects of Hydrochlorothiazide and Captopril on Glucose and Lipid Metabolism in Patients with Hypertension
863 Citations1989Thomas Pollare, Hans Lithell +1 more
Hydchlorothiazide for the treatment of essential hypertension has adverse effects on glucose and lipid metabolism and it is possible, but not proved, that these changes may contribute to the risk for diabetes mellitus and coronary heart disease.
Annals of Internal MedicineEchocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors
815 Citations1988Daniel Levy, KEAVEN M. ANDERSON +4 more
It is concluded that left ventricular hypertrophy is a common echocardiographic finding for which several risk factors can be identified and support weight reduction and blood pressure control for prevention or regression of this condition.
Archives of Internal MedicineImplications of Small Reductions in Diastolic Blood Pressure for Primary Prevention
805 Citations1995Nancy R. Cook
A small reduction of 2 mm Hg in DBP in the mean of the population distribution, in addition to medical treatment, could have a great public health impact on the number of CHD and stroke events prevented.
JAMAReversal of Left Ventricular Hypertrophy in Essential Hypertension
602 Citations1996Roland E. Schmieder
The ACE inhibitors and, to a lesser extent, calcium channel blockers emerged as first-line candidates to reduce the risk associated with left ventricular hypertrophy.
Blood PressureProspective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials
560 Citations1992Lennart Hansson, Thomas Hedner +1 more
A novel design for intervention studies is presented, the so called PROBE study (Prospective Randomized Open, Blinded End-point), which is compared to the classical double-blind design.
The LancetTREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
483 Citations1988Norman Sharpe, Heather Smith +2 more
In a randomised, double-blind trial 60 patients with left ventricular dysfunction but without clinical evidence of heart failure 1 week after Q wave myocardial infarction were given captopril 25 mg thrice a day, frusemide 40 mg daily, or placebo.
American Journal of HypertensionThe Effects of Initial Drug Choice and Comorbidity on Antihypertensive Therapy Compliance Results From a Population-Based Study in the Elderly
277 Citations1997Mark Monane
Drug choice, comorbidity, and health services utilization were significantly associated with AHT compliance and represent important considerations in the management of high blood pressure.
Medical CareThe Costs of Interrupting Antihypertensive Drug Therapy in a Medicaid Population
186 Citations1994Jeffrey S. McCombs, Michael B. Nichol +2 more
This research explores the association between the interruption or termination of antihypertensive drug therapy and total health care costs among non-institutionalized Medicaid patients older than age 40 who survive the first year after treatment.
Blood PressureThe 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH Meeting
157 Citations1993Alberto Zanchetti, John Chalmers +11 more
The new guidelines discuss the cardiovascular risk in patients with hypertension, the definition and classification of mild hypertension, drug treatment (including the elderly) and non-drug measures, cost-effectiveness, and further research.
DrugsLeft Ventricular Hypertrophy
116 Citations1988Daniel Levy
Ambulatory ECG results in subjects with echocardiographic LVH demonstrate increased risk for ventricular arrhythmias, which have been shown in other clinical settings to predict risk for sudden cardiac death.
HypertensionEffects of chronic angiotensin converting enzyme inhibition on glucose tolerance and insulin sensitivity in essential hypertension.
100 Citations1992D Santoro, Andrea Natali +5 more
The relation between the renin-angiotensin-aldosterone (RAA) system and carbohydrate metabolism and insulin sensitivity in essential hypertension has not been investigated systematically and higher plasma potassium levels before treatment predicted a better blood pressure response to ACE inhibition.
Blood PressureSTOP-Hypertension 2: A Prospective Intervention Trial of “Newer” versus “Older” Treatment Alternatives in Old Patients with Hypertension
89 Citations1993Björn Dahlöf, Lennart Hansson +6 more
STOP-Hypertension 2 will evaluate the therapy used in STOP- Hypertension 1 against therapy based on either ACE-inhibitors (enalapril and lisinopril) or on calcium antagonists (isradipine and felodipine), using the PROBE design (Prospective, Randomised, Open, Blinded Endpoint evaluation).
BMJCombined high blood pressure and glucose in type 2 diabetes: double jeopardy
84 Citations1998C. E. Mogensen
The UK study has provided answers to a range of important questions that have haunted diabetes researchers and clinicians for years, including Does a policy of tightly controlling blood glucose concentration reduce the risk of complications in type 2 diabetes?
PubMedCost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
50 Citations1994Hilleman De, Mohiuddin Sm +4 more
A systematic, retrospective, cost-minimization analysis of drugs used to treat 673 patients with newly diagnosed, mild-to-moderate diastolic hypertension between the years 1985 and 1992 found acquisition cost was often a poor predictor of the total cost of treatment.
Blood PressureACE Inhibition Preserves Renal Function Better than<i>bT</i>-blockade in the Treatment of Essential Hypertension
48 Citations1995Anders Himmelmänn, Lennart Hansson +5 more
The effects of two different antihypertensive therapies on the loss of GFR with time, determined with Cr51-EDTA clearance after 6, 12 and 24 months of treatment, were assessed in 257 patients with essential hypertension.
Blood PressureThe Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-2): A Progress Report
40 Citations1996Lars Lindholm, Lennart Hansson +6 more
In STOP-Hypertension-2, 6628 elderly hypertensive have been randomized to three different treatment regimes: beta-blocker+diuretics, ACE inhibitors, or calcium antagonists, and end-points have occurred at the expected rate.
American Journal of HypertensionElectrolyte Changes and Metabolic Effects of Lisinopril/Bendrofluazide Treatment Results From a Randomized, Double-Blind Study With Parallel Groups
39 Citations1994Arvo Haenni, Per‐Erik Andersson +3 more
Bendrofluazide treatment decreases the serum potassium concentration, reduces the initial insulin release and the glucose disposal, and, in addition, impairs insulin sensitivity, and alterations in serum potassium balance may affect the initial glucose release and glucose disposal.
European Journal of Clinical PharmacologyInsulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril
37 Citations1992Yves Allemann, Sandra Baumann +5 more
It is indicated that in healthy lean humans, ACE inhibition with fosinopril is neutral with regard to lipoprotein and carbohydrate metabolism, and that it may slightly enhance cellular glucose disposal.
Journal of HypertensionThe Captopril Prevention Project: a prospective intervention trial of angiotensin converting enzyme inhibition in the treatment of hypertension
32 Citations1990&NA; &NA;
The Captopril Prevention Project is a prospective, randomized, multi-centre intervention trial designed to investigate whether antihypertensive treatment with the angiotensin converting enzyme (ACE) inhibitor captopril may reduce cardiovascular mortality and morbidity more than a therapeutic regimen which does not include an ACE inhibitor.
Blood PressureThe Captopril Prevention Project (CAPPP) in Hypertension—Baseline Data and Current Status
28 Citations1997Lennart Hansson, Thomas Hedner +12 more
The baseline data and the changes in blood pressure during the first year in the total cohort are described and the average blood pressure was reduced by 11/8 mm Hg.
Survey of AnesthesiologyReversal of Left Ventricular Hypertrophy in Essential Hypertension
23 Citations1997R. Schmieder, Peter Martus +3 more
American Journal of HypertensionLong-term renal preservation in essential hypertension Angiotensin converting enzyme inhibition is superior to β-blockade
16 Citations1996A Himmelmann
It is demonstrated that in the treatment of essential hypertension ACE inhibition preserves GFR significantly better than beta-adrenoceptor blockade during long-term therapy.